๐ฐ Business
Live
AstraZeneca and Axsome Therapeutics drive VanEck Pharmaceutical ETF down 1.8%
The VanEck Pharmaceutical ETF (PPH) fell 1.8% on Monday, driven by a 7.2% drop in AstraZeneca and a 4.6% decline in Axsome Therapeutics. This downturn reflects investor caution amid economic uncertain
Nasdaq News โ 3 August 2026
Text:
21
0
0
The VanEck Pharmaceutical ETF (PPH) fell about 1.8% during Monday afternoon trading, making it one of the underperformers in the market. Key contribut
Read Full Story at Nasdaq News โ Sources
